Search

Author/Creator Liang, Weifeng

2. Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus. (23rd October 2017)

Authors:
Zheng, Shufa; Tang, Lingling; Gao, Hainv; Wang, Yiyin; Yu, Fei; Cui, Dawei; Xie, Guoliang; Yang, Xianzhi; Zhang, Wen; Ye, Xianfei; Zhang, Zike; Wang, Xi; Yu, Liang; Zhang, Yiming; Yang, Shigui; Liang, Weifeng; Chen, Yu; Li, Lanjuan
Journal:
Clinical infectious diseases
Issue:
Volume 66:Number 7(2018)
Page Start:
1054
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Discovery of the natural product 3', 4', 7, 8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor. (1st January 2021)

Authors:
Li, Jiao; Zou, Wei; Yu, Koukou; Liu, Bing; Liang, Weifeng; Wang, Lisha; Lu, Yin; Jiang, Zequn; Wang, Aiyun; Zhu, Jiapeng
Journal:
Journal of enzyme inhibition and medicinal chemistry
Issue:
Volume 36:Number 1(2021)
Page Start:
903
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study. Issue 1 (December 2015)

Authors:
Zhang, Yan; Gao, Hainv; Liang, Weifeng; Tang, Lingling; Yang, Yida; Wu, Xiaoxin; Yu, Liang; Chen, Ping; Zheng, Shufa; Ou, Huilin; Li, Lanjuan
Journal:
BMC infectious diseases
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗